At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1 enrolled
Drug / intervention
Injection of autologous stem cells +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use
In Brief
A clinical study evaluating Muscle Biopsy and Injection of autologous stem cells for Stress Urinary Incontinence. Completed, enrolled 1 participant across 2 sites.
Detailed Summary
Determine safety and effectiveness of the technique using autologous stem cells in the treatment of urinary incontinence in one male subject.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStress Urinary Incontinence
CountriesUnited States
CollaboratorsCorewell Health East
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2011
Primary CompletionJul 2012
First PostedJul 2012
Study CompletionJan 2016
TodayJul 2026
First PostedJul 24, 2012
Enrollment StartOct 1, 2011
Primary CompletionJul 1, 2012
Study CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 13.9 years ago
Interventions
Muscle Biopsyprocedure
Biopsy of thigh muscle to obtain stem cell core.
Injection of autologous stem cellsbiological
After autologous stem cells have multiplied over 6 weeks time they are injected into the subjects urethra.